These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15568408)

  • 1. Analgesic efficacy of French maritime pine bark extract in dysmenorrhea: an open clinical trial.
    Kohama T; Suzuki N; Ohno S; Inoue M
    J Reprod Med; 2004 Oct; 49(10):828-32. PubMed ID: 15568408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. French maritime pine bark extract significantly lowers the requirement for analgesic medication in dysmenorrhea: a multicenter, randomized, double-blind, placebo-controlled study.
    Suzuki N; Uebaba K; Kohama T; Moniwa N; Kanayama N; Koike K
    J Reprod Med; 2008 May; 53(5):338-46. PubMed ID: 18567279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of French maritime pine bark extract on endometriosis as compared with leuprorelin acetate.
    Kohama T; Herai K; Inoue M
    J Reprod Med; 2007 Aug; 52(8):703-8. PubMed ID: 17879831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women.
    Yang HM; Liao MF; Zhu SY; Liao MN; Rohdewald P
    Acta Obstet Gynecol Scand; 2007; 86(8):978-85. PubMed ID: 17653885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial.
    Davis AR; Westhoff C; O'Connell K; Gallagher N
    Obstet Gynecol; 2005 Jul; 106(1):97-104. PubMed ID: 15994623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pine bark extract (Pycnogenol) on symptoms of knee osteoarthritis.
    Cisár P; Jány R; Waczulíková I; Sumegová K; Muchová J; Vojtassák J; Duraćková Z; Lisý M; Rohdewald P
    Phytother Res; 2008 Aug; 22(8):1087-92. PubMed ID: 18570266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pycnogenol may alleviate adverse effects in oncologic treatment.
    Belcaro G; Cesarone MR; Genovesi D; Ledda A; Vinciguerra G; Ricci A; Pellegrini L; Gizzi G; Ippolito E; Dugall M; Cacchio M; Di Renzo A; Stuard S
    Panminerva Med; 2008 Sep; 50(3):227-34. PubMed ID: 18927527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women: a randomized, double-blind, placebo-controlled trial.
    Kohama T; Negami M
    J Reprod Med; 2013; 58(1-2):39-46. PubMed ID: 23447917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S; Robbins J; West CR; Nemeth MA
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a Psidii guajavae folium extract in the treatment of primary dysmenorrhea: a randomized clinical trial.
    Doubova SV; Morales HR; Hernández SF; del Carmen Martínez-García M; de Cossío Ortiz MG; Soto MA; Arce ER; Lozoya X
    J Ethnopharmacol; 2007 Mar; 110(2):305-10. PubMed ID: 17112693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary dysmenorrhea treated with sublingual piroxicam].
    Ragni N; Ciccarelli A
    Minerva Ginecol; 1993; 45(7-8):365-75. PubMed ID: 8414145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of glyceryl trinitrate with diclofenac for the treatment of primary dysmenorrhea: an open, randomized, cross-over trial.
    Facchinetti F; Sgarbi L; Piccinini F; Volpe A
    Gynecol Endocrinol; 2002 Feb; 16(1):39-43. PubMed ID: 11915580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of melasma with Pycnogenol.
    Ni Z; Mu Y; Gulati O
    Phytother Res; 2002 Sep; 16(6):567-71. PubMed ID: 12237816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans.
    Nishioka K; Hidaka T; Nakamura S; Umemura T; Jitsuiki D; Soga J; Goto C; Chayama K; Yoshizumi M; Higashi Y
    Hypertens Res; 2007 Sep; 30(9):775-80. PubMed ID: 18037769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol).
    Schäfer A; Chovanová Z; Muchová J; Sumegová K; Liptáková A; Duracková Z; Högger P
    Biomed Pharmacother; 2006 Jan; 60(1):5-9. PubMed ID: 16330178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized placebo-controlled trial of a flavonoid-rich plant extract-based cream in the treatment of rosacea.
    Rigopoulos D; Kalogeromitros D; Gregoriou S; Pacouret JM; Koch C; Fisher N; Bachmann K; Brown M; Schwarz E; Camel E; Katsambas A
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):564-8. PubMed ID: 16164709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. French maritime pine bark extract inhibits viral replication and prevents development of viral myocarditis.
    Matsumori A; Higuchi H; Shimada M
    J Card Fail; 2007 Nov; 13(9):785-91. PubMed ID: 17996829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial.
    Peloso PM; Fortin L; Beaulieu A; Kamin M; Rosenthal N;
    J Rheumatol; 2004 Dec; 31(12):2454-63. PubMed ID: 15570651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.